South Korea Biologics Market Growth, Demand and Challenges of the Key Industry Players 2024-32

1
South Korea Biologics Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "South Korea Biologics Market Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the South Korea biologics
  market size is projected to exhibit a growth rate
  (CAGR) of 7.06 during 2024-2032.
• The South Korea biologics market is experiencing
  significant growth, primarily driven by the
  country's rising focus on biotechnology and
  pharmaceutical innovation. In addition to this,
  the growing investment in research and
  development, state-of-the-art manufacturing
  facilities, and a favorable regulatory
  environment that encourages innovation and speeds
  up the commercialization of new therapies are
  further augmenting the market growth.
• Moreover, the launch of numerous initiatives by
  the government, such as the BioHealth 21
  Initiative, aimed at promoting the
  biopharmaceutical sector as a key factor of the
  country's future economic development, is
  creating a positive outlook for the market.
  Besides this, the growing acceptance of an
  ecosystem that includes both established
  pharmaceutical giants and emerging biotech firms,
  encouraging a competitive and dynamic environment
  for the development of novel biologic drugs, is
  also stimulating the market growth.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/south-korea-biologics-m
  arket/requestsample

4
Report Description

• South Korea Biologics Market Trends
• Furthermore, the increasing demand for biologics
  in South Korea due to an aging population and the
  escalating prevalence of chronic disorders, such
  as cancer, diabetes, and autoimmune disorders,
  which require advanced therapeutic interventions,
  is acting as another significant growth-inducing
  factor. Apart from this, the rising preference
  for biologics over traditional pharmaceuticals
  owing to their ability to target specific disease
  mechanisms with fewer side effects, is also
  contributing to the market growth.
• Additionally, the increasing partnerships and
  collaborations between South Korea and global
  biopharmaceutical companies, enhancing its
  capabilities in biologics RD, are creating a
  positive outlook for the market. Moreover,
  continuous innovation, an effective pipeline of
  biologic drugs, and elevating government support,
  are projected to propel the South Korea biologics
  market over the forecasted period.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/south-korea-biologics-m
  arket

5
Report Segmentation

• Source Insights
• Microbial
• Mammalian
• Others
•  
• Product Insights
• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Antisense, RNAi and Molecular Therapy
• Others
• Disease Insights
• Oncology
• Immunological Disorders
• Cardiovascular Disorders

6
Report Segmentation

• Hematological Disorders
• Others
• Manufacturing Insights
• Outsourced
• In-House
• Regional Insights
• Seoul Capital Area
• Yeongnam (Southeastern Region)
• Honam (Southwestern Region)
• Hoseo (Central Region)
• Others

7
Key Questions Answered in the Report
8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4 South
  Korea Biologics Market - Introduction
• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence
• 5 South Korea Biologics Market Landscape
• 5.1 Historical and Current Market Trends
  (2018-2023)
• 5.2 Market Forecast (?2024-2032)
• 6 South Korea Biologics Market - Breakup by
  Source
• 6.1 Microbial
• 6.1.1 Overview
• 6.1.2 Historical and Current Market
  Trends (2018-2023)
• 6.1.3 Market Forecast (?2024-2032)
• 6.2 Mammalian
• 6.2.1 Overview
• 6.2.2 Historical and Current Market
  Trends (2018-2023)
• 6.2.3 Market Forecast (?2024-2032)     
   

10
Table of Contents

• 6.3 Others
• 6.3.1 Historical and Current Market
  Trends (2018-2023)
• 6.3.2 Market Forecast (?2024-2032)
• 7 South Korea Biologics Market - Breakup by
  Product
• 7.1 Monoclonal Antibodies
• 7.1.1 Overview
• 7.1.2 Historical and Current Market
  Trends (2018-2023)
• 7.1.3 Market Forecast (?2024-2032)
• 7.2 Vaccines
• 7.2.1 Overview
• 7.2.2 Historical and Current Market
  Trends (2018-2023)
• 7.2.3 Market Forecast (?2024-2032)
• 7.3 Recombinant Proteins
• 7.3.1 Overview
• 7.3.2 Historical and Current Market
  Trends (2018-2023)
• 7.3.3 Market Forecast (?2024-2032)
• 7.4 Antisense, RNAi and Molecular Therapy
• 7.4.1 Overview
• 7.4.2 Historical and Current Market
  Trends (2018-2023)

11
Partial List of Clients
12
Partial List of Clients
13
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

14
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us